文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

免疫细胞向肿瘤的迁移。

Immune Cell Migration to Cancer.

机构信息

Department of Microbiology and Immunology, University of Rochester, Rochester, NY 14642, USA.

David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, NY 14642, USA.

出版信息

Cells. 2024 May 16;13(10):844. doi: 10.3390/cells13100844.


DOI:10.3390/cells13100844
PMID:38786066
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11120175/
Abstract

Immune cell migration is required for the development of an effective and robust immune response. This elegant process is regulated by both cellular and environmental factors, with variables such as immune cell state, anatomical location, and disease state that govern differences in migration patterns. In all cases, a major factor is the expression of cell surface receptors and their cognate ligands. Rapid adaptation to environmental conditions partly depends on intrinsic cellular immune factors that affect a cell's ability to adjust to new environment. In this review, we discuss both myeloid and lymphoid cells and outline key determinants that govern immune cell migration, including molecules required for immune cell adhesion, modes of migration, chemotaxis, and specific chemokine signaling. Furthermore, we summarize tumor-specific elements that contribute to immune cell trafficking to cancer, while also exploring microenvironment factors that can alter these cellular dynamics within the tumor in both a pro and antitumor fashion. Specifically, we highlight the importance of the secretome in these later aspects. This review considers a myriad of factors that impact immune cell trajectory in cancer. We aim to highlight the immunotherapeutic targets that can be harnessed to achieve controlled immune trafficking to and within tumors.

摘要

免疫细胞的迁移对于产生有效和强大的免疫反应是必需的。这个优雅的过程受到细胞和环境因素的调节,免疫细胞的状态、解剖位置和疾病状态等变量决定了迁移模式的差异。在所有情况下,一个主要因素是细胞表面受体及其配体的表达。对环境条件的快速适应部分取决于内在的细胞免疫因素,这些因素影响细胞适应新环境的能力。在这篇综述中,我们讨论了髓系和淋巴系细胞,并概述了控制免疫细胞迁移的关键决定因素,包括免疫细胞黏附所需的分子、迁移模式、趋化性以及特定趋化因子信号。此外,我们总结了肿瘤特异性因素有助于免疫细胞向癌症的转移,同时还探讨了微环境因素可以以促进和抑制肿瘤的方式改变肿瘤内这些细胞的动态。具体来说,我们强调了分泌组在这些方面的重要性。本综述考虑了影响癌症中免疫细胞轨迹的众多因素。我们旨在强调可以利用免疫治疗靶点来实现对肿瘤内外的免疫细胞的控制性迁移。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d52e/11120175/e48161cba8d4/cells-13-00844-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d52e/11120175/c5b068b26796/cells-13-00844-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d52e/11120175/754c5c17a881/cells-13-00844-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d52e/11120175/fbb4099418f2/cells-13-00844-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d52e/11120175/2a83f3197870/cells-13-00844-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d52e/11120175/35b4cb29dd37/cells-13-00844-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d52e/11120175/e48161cba8d4/cells-13-00844-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d52e/11120175/c5b068b26796/cells-13-00844-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d52e/11120175/754c5c17a881/cells-13-00844-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d52e/11120175/fbb4099418f2/cells-13-00844-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d52e/11120175/2a83f3197870/cells-13-00844-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d52e/11120175/35b4cb29dd37/cells-13-00844-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d52e/11120175/e48161cba8d4/cells-13-00844-g006.jpg

相似文献

[1]
Immune Cell Migration to Cancer.

Cells. 2024-5-16

[2]
The Role of CXC Chemokine Receptors 1-4 on Immune Cells in the Tumor Microenvironment.

Front Immunol. 2018-9-25

[3]
Emerging role of mTOR in tumor immune contexture: Impact on chemokine-related immune cells migration.

Theranostics. 2020

[4]
Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy.

JCI Insight. 2019-4-4

[5]
Dendritic Cells in the Tumor Microenvironment.

Adv Exp Med Biol. 2020

[6]
Chemokines in cancer.

Cancer Immunol Res. 2014-12

[7]
Functional and mechanistic advantage of the use of a bifunctional anti-PD-L1/IL-15 superagonist.

J Immunother Cancer. 2020-4

[8]
Myeloid regulatory cells in tumor spreading and metastasis.

Immunobiology. 2015-2

[9]
Myeloid-derived suppressor cells: Key immunosuppressive regulators and therapeutic targets in cancer.

Pathol Res Pract. 2023-8

[10]
Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia.

Am J Physiol Cell Physiol. 2015-11-1

引用本文的文献

[1]
Ultrasound-Triggered NPC1L1-Targeting Nanobubbles for Remodeling the Tumor Microenvironment in Pancreatic Cancer Chemoimmunotherapy.

ACS Appl Mater Interfaces. 2025-6-18

[2]
Migration Dynamics of Human NK Cell Preparations in Microchannels and Their Invasion Into Patient-Derived Tissue.

J Cell Mol Med. 2025-4

[3]
Single-cell transcriptomics analysis reveals that the tumor-infiltrating B cells determine the indolent fate of papillary thyroid carcinoma.

J Exp Clin Cancer Res. 2025-3-11

[4]
Molecular Pathways Linking High-Fat Diet and PM Exposure to Metabolically Abnormal Obesity: A Systematic Review and Meta-Analysis.

Biomolecules. 2024-12-16

[5]
Cancer Immunotherapy Using AIRE Conditioning of the Tumor Epitopeome.

Res Sq. 2024-11-15

[6]
Immune dynamics shaping pre-metastatic and metastatic niches in liver metastases: from molecular mechanisms to therapeutic strategies.

Mol Cancer. 2024-11-14

[7]
Cold and hot tumors: from molecular mechanisms to targeted therapy.

Signal Transduct Target Ther. 2024-10-18

[8]
The Laws of Attraction: Chemokines as Critical Mediators in Cancer Progression and Immunotherapy Response in Bladder Cancer.

Cancers (Basel). 2024-9-27

[9]
Recent Treatment Strategies and Molecular Pathways in Resistance Mechanisms of Antiangiogenic Therapies in Glioblastoma.

Cancers (Basel). 2024-8-27

本文引用的文献

[1]
Sepsis-trained macrophages promote antitumoral tissue-resident T cells.

Nat Immunol. 2024-5

[2]
Endothelial CXCR2 deficiency attenuates renal inflammation and glycocalyx shedding through NF-κB signaling in diabetic kidney disease.

Cell Commun Signal. 2024-3-25

[3]
Unveiling CXCR2 as a promising therapeutic target in renal cell carcinoma: exploring the immunotherapeutic paradigm shift through its inhibition by RCT001.

J Exp Clin Cancer Res. 2024-3-19

[4]
Human lung cancer harbors spatially organized stem-immunity hubs associated with response to immunotherapy.

Nat Immunol. 2024-4

[5]
Mitochondrial metabolism sustains CD8 T cell migration for an efficient infiltration into solid tumors.

Nat Commun. 2024-3-11

[6]
Combining TIGIT Blockade with MDSC Inhibition Hinders Breast Cancer Bone Metastasis by Activating Antitumor Immunity.

Cancer Discov. 2024-7-1

[7]
The pathogenesis of cancer-associated thrombosis.

Int J Hematol. 2024-5

[8]
TGF-β1-Induced SOX18 Elevation Promotes Hepatocellular Carcinoma Progression and Metastasis Through Transcriptionally Upregulating PD-L1 and CXCL12.

Gastroenterology. 2024-7

[9]
IL-37 dampens immunosuppressive functions of MDSCs via metabolic reprogramming in the tumor microenvironment.

Cell Rep. 2024-3-26

[10]
ICAMs in Immunity, Intercellular Adhesion and Communication.

Cells. 2024-2-14

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索